nodes	percent_of_prediction	percent_of_DWPC	metapath
Anastrozole—CYP1A2—Sorafenib—liver cancer	0.101	0.365	CbGbCtD
Anastrozole—CYP2C9—Sorafenib—liver cancer	0.0908	0.329	CbGbCtD
Anastrozole—CYP3A4—Sorafenib—liver cancer	0.0528	0.191	CbGbCtD
Anastrozole—CYP3A4—Doxorubicin—liver cancer	0.032	0.116	CbGbCtD
Anastrozole—Vaginal haemorrhage—Epirubicin—liver cancer	0.00237	0.00469	CcSEcCtD
Anastrozole—Hypercalcaemia—Doxorubicin—liver cancer	0.00233	0.00462	CcSEcCtD
Anastrozole—Thrombosis—Doxorubicin—liver cancer	0.00229	0.00453	CcSEcCtD
Anastrozole—Erythema multiforme—Sorafenib—liver cancer	0.00225	0.00446	CcSEcCtD
Anastrozole—Blister—Doxorubicin—liver cancer	0.00225	0.00445	CcSEcCtD
Anastrozole—Vaginal haemorrhage—Doxorubicin—liver cancer	0.00219	0.00434	CcSEcCtD
Anastrozole—Ageusia—Epirubicin—liver cancer	0.00216	0.00428	CcSEcCtD
Anastrozole—Alopecia—Sorafenib—liver cancer	0.0021	0.00416	CcSEcCtD
Anastrozole—Erythema—Sorafenib—liver cancer	0.00207	0.0041	CcSEcCtD
Anastrozole—Neoplasm malignant—Epirubicin—liver cancer	0.00205	0.00406	CcSEcCtD
Anastrozole—Dysgeusia—Sorafenib—liver cancer	0.00203	0.00402	CcSEcCtD
Anastrozole—Breast pain—Epirubicin—liver cancer	0.00201	0.00398	CcSEcCtD
Anastrozole—Ageusia—Doxorubicin—liver cancer	0.002	0.00396	CcSEcCtD
Anastrozole—Vasodilation—Epirubicin—liver cancer	0.00199	0.00395	CcSEcCtD
Anastrozole—Vasodilation procedure—Epirubicin—liver cancer	0.00199	0.00395	CcSEcCtD
Anastrozole—Cardiovascular disorder—Epirubicin—liver cancer	0.00199	0.00395	CcSEcCtD
Anastrozole—Arthropathy—Epirubicin—liver cancer	0.00193	0.00381	CcSEcCtD
Anastrozole—Anaemia—Sorafenib—liver cancer	0.00192	0.00379	CcSEcCtD
Anastrozole—Cough increased—Epirubicin—liver cancer	0.00191	0.00379	CcSEcCtD
Anastrozole—Neoplasm malignant—Doxorubicin—liver cancer	0.0019	0.00376	CcSEcCtD
Anastrozole—Angioedema—Sorafenib—liver cancer	0.00189	0.00375	CcSEcCtD
Anastrozole—Breast pain—Doxorubicin—liver cancer	0.00186	0.00368	CcSEcCtD
Anastrozole—Leukopenia—Sorafenib—liver cancer	0.00186	0.00367	CcSEcCtD
Anastrozole—Ulcer—Epirubicin—liver cancer	0.00185	0.00367	CcSEcCtD
Anastrozole—Vasodilation—Doxorubicin—liver cancer	0.00185	0.00365	CcSEcCtD
Anastrozole—Vasodilation procedure—Doxorubicin—liver cancer	0.00185	0.00365	CcSEcCtD
Anastrozole—Cardiovascular disorder—Doxorubicin—liver cancer	0.00185	0.00365	CcSEcCtD
Anastrozole—Bone pain—Epirubicin—liver cancer	0.00183	0.00362	CcSEcCtD
Anastrozole—Cough—Sorafenib—liver cancer	0.00181	0.00358	CcSEcCtD
Anastrozole—Inflammation—Epirubicin—liver cancer	0.00181	0.00358	CcSEcCtD
Anastrozole—Hypertension—Sorafenib—liver cancer	0.00179	0.00354	CcSEcCtD
Anastrozole—Arthropathy—Doxorubicin—liver cancer	0.00178	0.00353	CcSEcCtD
Anastrozole—Neck pain—Epirubicin—liver cancer	0.00177	0.00351	CcSEcCtD
Anastrozole—Cough increased—Doxorubicin—liver cancer	0.00177	0.00351	CcSEcCtD
Anastrozole—Arthralgia—Sorafenib—liver cancer	0.00176	0.00349	CcSEcCtD
Anastrozole—Myalgia—Sorafenib—liver cancer	0.00176	0.00349	CcSEcCtD
Anastrozole—Vaginal inflammation—Epirubicin—liver cancer	0.00175	0.00347	CcSEcCtD
Anastrozole—Phosphatase alkaline increased—Epirubicin—liver cancer	0.00175	0.00347	CcSEcCtD
Anastrozole—Pulmonary embolism—Epirubicin—liver cancer	0.00175	0.00347	CcSEcCtD
Anastrozole—Dry mouth—Sorafenib—liver cancer	0.00173	0.00342	CcSEcCtD
Anastrozole—Ulcer—Doxorubicin—liver cancer	0.00171	0.00339	CcSEcCtD
Anastrozole—Influenza like illness—Epirubicin—liver cancer	0.0017	0.00337	CcSEcCtD
Anastrozole—Bone pain—Doxorubicin—liver cancer	0.00169	0.00335	CcSEcCtD
Anastrozole—Anaphylactic shock—Sorafenib—liver cancer	0.00169	0.00335	CcSEcCtD
Anastrozole—Infection—Sorafenib—liver cancer	0.00168	0.00333	CcSEcCtD
Anastrozole—Inflammation—Doxorubicin—liver cancer	0.00167	0.00331	CcSEcCtD
Anastrozole—Vaginal infection—Epirubicin—liver cancer	0.00165	0.00327	CcSEcCtD
Anastrozole—Neuropathy—Epirubicin—liver cancer	0.00165	0.00326	CcSEcCtD
Anastrozole—Neck pain—Doxorubicin—liver cancer	0.00164	0.00325	CcSEcCtD
Anastrozole—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.00162	0.00321	CcSEcCtD
Anastrozole—Vaginal inflammation—Doxorubicin—liver cancer	0.00162	0.00321	CcSEcCtD
Anastrozole—Pulmonary embolism—Doxorubicin—liver cancer	0.00162	0.00321	CcSEcCtD
Anastrozole—Anorexia—Sorafenib—liver cancer	0.00161	0.00319	CcSEcCtD
Anastrozole—Neoplasm—Epirubicin—liver cancer	0.00158	0.00314	CcSEcCtD
Anastrozole—Influenza like illness—Doxorubicin—liver cancer	0.00157	0.00312	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00154	0.00305	CcSEcCtD
Anastrozole—Hypertonia—Epirubicin—liver cancer	0.00154	0.00304	CcSEcCtD
Anastrozole—Vaginal infection—Doxorubicin—liver cancer	0.00153	0.00303	CcSEcCtD
Anastrozole—Neuropathy—Doxorubicin—liver cancer	0.00152	0.00301	CcSEcCtD
Anastrozole—Dyspnoea—Sorafenib—liver cancer	0.00151	0.00299	CcSEcCtD
Anastrozole—Dyspepsia—Sorafenib—liver cancer	0.00149	0.00295	CcSEcCtD
Anastrozole—Decreased appetite—Sorafenib—liver cancer	0.00147	0.00291	CcSEcCtD
Anastrozole—Thrombophlebitis—Epirubicin—liver cancer	0.00147	0.00291	CcSEcCtD
Anastrozole—Neoplasm—Doxorubicin—liver cancer	0.00147	0.0029	CcSEcCtD
Anastrozole—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00146	0.00289	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Sorafenib—liver cancer	0.00146	0.00289	CcSEcCtD
Anastrozole—Fatigue—Sorafenib—liver cancer	0.00146	0.00289	CcSEcCtD
Anastrozole—Pain—Sorafenib—liver cancer	0.00145	0.00286	CcSEcCtD
Anastrozole—Constipation—Sorafenib—liver cancer	0.00145	0.00286	CcSEcCtD
Anastrozole—Hypertonia—Doxorubicin—liver cancer	0.00142	0.00281	CcSEcCtD
Anastrozole—Gastrointestinal pain—Sorafenib—liver cancer	0.00138	0.00274	CcSEcCtD
Anastrozole—Hot flush—Epirubicin—liver cancer	0.00136	0.00269	CcSEcCtD
Anastrozole—Thrombophlebitis—Doxorubicin—liver cancer	0.00136	0.00269	CcSEcCtD
Anastrozole—Increased appetite—Epirubicin—liver cancer	0.00135	0.00268	CcSEcCtD
Anastrozole—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00135	0.00268	CcSEcCtD
Anastrozole—Menopausal symptoms—Epirubicin—liver cancer	0.00135	0.00267	CcSEcCtD
Anastrozole—Urticaria—Sorafenib—liver cancer	0.00134	0.00266	CcSEcCtD
Anastrozole—Body temperature increased—Sorafenib—liver cancer	0.00134	0.00265	CcSEcCtD
Anastrozole—Abdominal pain—Sorafenib—liver cancer	0.00134	0.00265	CcSEcCtD
Anastrozole—Dermatitis bullous—Epirubicin—liver cancer	0.00133	0.00263	CcSEcCtD
Anastrozole—Anaphylactoid reaction—Epirubicin—liver cancer	0.00131	0.0026	CcSEcCtD
Anastrozole—Cerebrovascular accident—Epirubicin—liver cancer	0.0013	0.00257	CcSEcCtD
Anastrozole—Lethargy—Epirubicin—liver cancer	0.0013	0.00257	CcSEcCtD
Anastrozole—Osteoarthritis—Epirubicin—liver cancer	0.00127	0.00252	CcSEcCtD
Anastrozole—Hot flush—Doxorubicin—liver cancer	0.00126	0.00249	CcSEcCtD
Anastrozole—Increased appetite—Doxorubicin—liver cancer	0.00125	0.00248	CcSEcCtD
Anastrozole—Menopausal symptoms—Doxorubicin—liver cancer	0.00125	0.00247	CcSEcCtD
Anastrozole—Hypersensitivity—Sorafenib—liver cancer	0.00125	0.00247	CcSEcCtD
Anastrozole—Dermatitis bullous—Doxorubicin—liver cancer	0.00123	0.00244	CcSEcCtD
Anastrozole—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00122	0.00241	CcSEcCtD
Anastrozole—Asthenia—Sorafenib—liver cancer	0.00121	0.0024	CcSEcCtD
Anastrozole—Mood swings—Epirubicin—liver cancer	0.00121	0.00239	CcSEcCtD
Anastrozole—Lethargy—Doxorubicin—liver cancer	0.0012	0.00238	CcSEcCtD
Anastrozole—Cerebrovascular accident—Doxorubicin—liver cancer	0.0012	0.00238	CcSEcCtD
Anastrozole—Pruritus—Sorafenib—liver cancer	0.0012	0.00237	CcSEcCtD
Anastrozole—Osteoarthritis—Doxorubicin—liver cancer	0.00118	0.00233	CcSEcCtD
Anastrozole—Liver function test abnormal—Epirubicin—liver cancer	0.00117	0.00232	CcSEcCtD
Anastrozole—Diarrhoea—Sorafenib—liver cancer	0.00116	0.00229	CcSEcCtD
Anastrozole—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00115	0.00227	CcSEcCtD
Anastrozole—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00112	0.00222	CcSEcCtD
Anastrozole—Dizziness—Sorafenib—liver cancer	0.00112	0.00221	CcSEcCtD
Anastrozole—Mood swings—Doxorubicin—liver cancer	0.00112	0.00221	CcSEcCtD
Anastrozole—Dysphagia—Epirubicin—liver cancer	0.0011	0.00218	CcSEcCtD
Anastrozole—Influenza—Epirubicin—liver cancer	0.0011	0.00218	CcSEcCtD
Anastrozole—Liver function test abnormal—Doxorubicin—liver cancer	0.00109	0.00215	CcSEcCtD
Anastrozole—Vomiting—Sorafenib—liver cancer	0.00108	0.00213	CcSEcCtD
Anastrozole—Angina pectoris—Epirubicin—liver cancer	0.00107	0.00212	CcSEcCtD
Anastrozole—Rash—Sorafenib—liver cancer	0.00107	0.00211	CcSEcCtD
Anastrozole—Dermatitis—Sorafenib—liver cancer	0.00107	0.00211	CcSEcCtD
Anastrozole—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00106	0.0021	CcSEcCtD
Anastrozole—Headache—Sorafenib—liver cancer	0.00106	0.0021	CcSEcCtD
Anastrozole—Bronchitis—Epirubicin—liver cancer	0.00106	0.00209	CcSEcCtD
Anastrozole—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00104	0.00205	CcSEcCtD
Anastrozole—Influenza—Doxorubicin—liver cancer	0.00102	0.00201	CcSEcCtD
Anastrozole—Dysphagia—Doxorubicin—liver cancer	0.00102	0.00201	CcSEcCtD
Anastrozole—Nausea—Sorafenib—liver cancer	0.00101	0.00199	CcSEcCtD
Anastrozole—Weight increased—Epirubicin—liver cancer	0.001	0.00198	CcSEcCtD
Anastrozole—Weight decreased—Epirubicin—liver cancer	0.000995	0.00197	CcSEcCtD
Anastrozole—Angina pectoris—Doxorubicin—liver cancer	0.000991	0.00196	CcSEcCtD
Anastrozole—Bronchitis—Doxorubicin—liver cancer	0.000978	0.00194	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000972	0.00192	CcSEcCtD
Anastrozole—Neuropathy peripheral—Epirubicin—liver cancer	0.000961	0.0019	CcSEcCtD
Anastrozole—Jaundice—Epirubicin—liver cancer	0.000956	0.00189	CcSEcCtD
Anastrozole—Urinary tract infection—Epirubicin—liver cancer	0.000953	0.00189	CcSEcCtD
Anastrozole—Sweating—Epirubicin—liver cancer	0.00094	0.00186	CcSEcCtD
Anastrozole—Hepatobiliary disease—Epirubicin—liver cancer	0.000927	0.00183	CcSEcCtD
Anastrozole—Weight increased—Doxorubicin—liver cancer	0.000926	0.00183	CcSEcCtD
Anastrozole—Weight decreased—Doxorubicin—liver cancer	0.00092	0.00182	CcSEcCtD
Anastrozole—Sinusitis—Epirubicin—liver cancer	0.00092	0.00182	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000899	0.00178	CcSEcCtD
Anastrozole—Neuropathy peripheral—Doxorubicin—liver cancer	0.000889	0.00176	CcSEcCtD
Anastrozole—Haemoglobin—Epirubicin—liver cancer	0.000885	0.00175	CcSEcCtD
Anastrozole—Jaundice—Doxorubicin—liver cancer	0.000884	0.00175	CcSEcCtD
Anastrozole—Rhinitis—Epirubicin—liver cancer	0.000882	0.00175	CcSEcCtD
Anastrozole—Urinary tract infection—Doxorubicin—liver cancer	0.000882	0.00174	CcSEcCtD
Anastrozole—Hepatitis—Epirubicin—liver cancer	0.00088	0.00174	CcSEcCtD
Anastrozole—Haemorrhage—Epirubicin—liver cancer	0.00088	0.00174	CcSEcCtD
Anastrozole—Pharyngitis—Epirubicin—liver cancer	0.000874	0.00173	CcSEcCtD
Anastrozole—Sweating—Doxorubicin—liver cancer	0.00087	0.00172	CcSEcCtD
Anastrozole—Oedema peripheral—Epirubicin—liver cancer	0.000867	0.00172	CcSEcCtD
Anastrozole—Hepatobiliary disease—Doxorubicin—liver cancer	0.000858	0.0017	CcSEcCtD
Anastrozole—Sinusitis—Doxorubicin—liver cancer	0.000851	0.00168	CcSEcCtD
Anastrozole—Erythema multiforme—Epirubicin—liver cancer	0.000832	0.00165	CcSEcCtD
Anastrozole—Haemoglobin—Doxorubicin—liver cancer	0.000819	0.00162	CcSEcCtD
Anastrozole—Rhinitis—Doxorubicin—liver cancer	0.000816	0.00162	CcSEcCtD
Anastrozole—Haemorrhage—Doxorubicin—liver cancer	0.000814	0.00161	CcSEcCtD
Anastrozole—Hepatitis—Doxorubicin—liver cancer	0.000814	0.00161	CcSEcCtD
Anastrozole—Pharyngitis—Doxorubicin—liver cancer	0.000808	0.0016	CcSEcCtD
Anastrozole—Oedema peripheral—Doxorubicin—liver cancer	0.000802	0.00159	CcSEcCtD
Anastrozole—Alopecia—Epirubicin—liver cancer	0.000778	0.00154	CcSEcCtD
Anastrozole—Erythema multiforme—Doxorubicin—liver cancer	0.00077	0.00152	CcSEcCtD
Anastrozole—Erythema—Epirubicin—liver cancer	0.000766	0.00152	CcSEcCtD
Anastrozole—Tension—Epirubicin—liver cancer	0.000752	0.00149	CcSEcCtD
Anastrozole—Dysgeusia—Epirubicin—liver cancer	0.00075	0.00148	CcSEcCtD
Anastrozole—Nervousness—Epirubicin—liver cancer	0.000744	0.00147	CcSEcCtD
Anastrozole—Back pain—Epirubicin—liver cancer	0.000741	0.00147	CcSEcCtD
Anastrozole—Alopecia—Doxorubicin—liver cancer	0.00072	0.00142	CcSEcCtD
Anastrozole—Ill-defined disorder—Epirubicin—liver cancer	0.000711	0.00141	CcSEcCtD
Anastrozole—Erythema—Doxorubicin—liver cancer	0.000709	0.0014	CcSEcCtD
Anastrozole—Anaemia—Epirubicin—liver cancer	0.000708	0.0014	CcSEcCtD
Anastrozole—Tension—Doxorubicin—liver cancer	0.000696	0.00138	CcSEcCtD
Anastrozole—Dysgeusia—Doxorubicin—liver cancer	0.000694	0.00137	CcSEcCtD
Anastrozole—Malaise—Epirubicin—liver cancer	0.000691	0.00137	CcSEcCtD
Anastrozole—Nervousness—Doxorubicin—liver cancer	0.000689	0.00136	CcSEcCtD
Anastrozole—Leukopenia—Epirubicin—liver cancer	0.000686	0.00136	CcSEcCtD
Anastrozole—Back pain—Doxorubicin—liver cancer	0.000686	0.00136	CcSEcCtD
Anastrozole—Cough—Epirubicin—liver cancer	0.000669	0.00132	CcSEcCtD
Anastrozole—Hypertension—Epirubicin—liver cancer	0.000661	0.00131	CcSEcCtD
Anastrozole—Ill-defined disorder—Doxorubicin—liver cancer	0.000658	0.0013	CcSEcCtD
Anastrozole—Anaemia—Doxorubicin—liver cancer	0.000655	0.0013	CcSEcCtD
Anastrozole—Arthralgia—Epirubicin—liver cancer	0.000652	0.00129	CcSEcCtD
Anastrozole—Chest pain—Epirubicin—liver cancer	0.000652	0.00129	CcSEcCtD
Anastrozole—Myalgia—Epirubicin—liver cancer	0.000652	0.00129	CcSEcCtD
Anastrozole—Anxiety—Epirubicin—liver cancer	0.00065	0.00129	CcSEcCtD
Anastrozole—Discomfort—Epirubicin—liver cancer	0.000644	0.00128	CcSEcCtD
Anastrozole—Malaise—Doxorubicin—liver cancer	0.000639	0.00127	CcSEcCtD
Anastrozole—Dry mouth—Epirubicin—liver cancer	0.000638	0.00126	CcSEcCtD
Anastrozole—Leukopenia—Doxorubicin—liver cancer	0.000635	0.00126	CcSEcCtD
Anastrozole—Confusional state—Epirubicin—liver cancer	0.00063	0.00125	CcSEcCtD
Anastrozole—Oedema—Epirubicin—liver cancer	0.000625	0.00124	CcSEcCtD
Anastrozole—Anaphylactic shock—Epirubicin—liver cancer	0.000625	0.00124	CcSEcCtD
Anastrozole—Infection—Epirubicin—liver cancer	0.000621	0.00123	CcSEcCtD
Anastrozole—Cough—Doxorubicin—liver cancer	0.000619	0.00122	CcSEcCtD
Anastrozole—Hypertension—Doxorubicin—liver cancer	0.000612	0.00121	CcSEcCtD
Anastrozole—Hyperhidrosis—Epirubicin—liver cancer	0.000604	0.0012	CcSEcCtD
Anastrozole—Myalgia—Doxorubicin—liver cancer	0.000604	0.00119	CcSEcCtD
Anastrozole—Chest pain—Doxorubicin—liver cancer	0.000604	0.00119	CcSEcCtD
Anastrozole—Arthralgia—Doxorubicin—liver cancer	0.000604	0.00119	CcSEcCtD
Anastrozole—Anxiety—Doxorubicin—liver cancer	0.000601	0.00119	CcSEcCtD
Anastrozole—Discomfort—Doxorubicin—liver cancer	0.000596	0.00118	CcSEcCtD
Anastrozole—Anorexia—Epirubicin—liver cancer	0.000596	0.00118	CcSEcCtD
Anastrozole—Dry mouth—Doxorubicin—liver cancer	0.00059	0.00117	CcSEcCtD
Anastrozole—Confusional state—Doxorubicin—liver cancer	0.000583	0.00115	CcSEcCtD
Anastrozole—Anaphylactic shock—Doxorubicin—liver cancer	0.000579	0.00114	CcSEcCtD
Anastrozole—Oedema—Doxorubicin—liver cancer	0.000579	0.00114	CcSEcCtD
Anastrozole—Infection—Doxorubicin—liver cancer	0.000575	0.00114	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00057	0.00113	CcSEcCtD
Anastrozole—Insomnia—Epirubicin—liver cancer	0.000566	0.00112	CcSEcCtD
Anastrozole—Paraesthesia—Epirubicin—liver cancer	0.000561	0.00111	CcSEcCtD
Anastrozole—Hyperhidrosis—Doxorubicin—liver cancer	0.000559	0.00111	CcSEcCtD
Anastrozole—Dyspnoea—Epirubicin—liver cancer	0.000557	0.0011	CcSEcCtD
Anastrozole—Somnolence—Epirubicin—liver cancer	0.000556	0.0011	CcSEcCtD
Anastrozole—Anorexia—Doxorubicin—liver cancer	0.000552	0.00109	CcSEcCtD
Anastrozole—Dyspepsia—Epirubicin—liver cancer	0.00055	0.00109	CcSEcCtD
Anastrozole—Decreased appetite—Epirubicin—liver cancer	0.000544	0.00108	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Epirubicin—liver cancer	0.00054	0.00107	CcSEcCtD
Anastrozole—Fatigue—Epirubicin—liver cancer	0.000539	0.00107	CcSEcCtD
Anastrozole—Pain—Epirubicin—liver cancer	0.000535	0.00106	CcSEcCtD
Anastrozole—Constipation—Epirubicin—liver cancer	0.000535	0.00106	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000527	0.00104	CcSEcCtD
Anastrozole—Insomnia—Doxorubicin—liver cancer	0.000523	0.00104	CcSEcCtD
Anastrozole—Paraesthesia—Doxorubicin—liver cancer	0.00052	0.00103	CcSEcCtD
Anastrozole—Dyspnoea—Doxorubicin—liver cancer	0.000516	0.00102	CcSEcCtD
Anastrozole—Feeling abnormal—Epirubicin—liver cancer	0.000515	0.00102	CcSEcCtD
Anastrozole—Somnolence—Doxorubicin—liver cancer	0.000514	0.00102	CcSEcCtD
Anastrozole—Gastrointestinal pain—Epirubicin—liver cancer	0.000511	0.00101	CcSEcCtD
Anastrozole—Dyspepsia—Doxorubicin—liver cancer	0.000509	0.00101	CcSEcCtD
Anastrozole—Decreased appetite—Doxorubicin—liver cancer	0.000503	0.000995	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Doxorubicin—liver cancer	0.0005	0.000988	CcSEcCtD
Anastrozole—Fatigue—Doxorubicin—liver cancer	0.000499	0.000987	CcSEcCtD
Anastrozole—Urticaria—Epirubicin—liver cancer	0.000497	0.000983	CcSEcCtD
Anastrozole—Pain—Doxorubicin—liver cancer	0.000495	0.000979	CcSEcCtD
Anastrozole—Constipation—Doxorubicin—liver cancer	0.000495	0.000979	CcSEcCtD
Anastrozole—Abdominal pain—Epirubicin—liver cancer	0.000494	0.000978	CcSEcCtD
Anastrozole—Body temperature increased—Epirubicin—liver cancer	0.000494	0.000978	CcSEcCtD
Anastrozole—Feeling abnormal—Doxorubicin—liver cancer	0.000477	0.000943	CcSEcCtD
Anastrozole—Gastrointestinal pain—Doxorubicin—liver cancer	0.000473	0.000936	CcSEcCtD
Anastrozole—Hypersensitivity—Epirubicin—liver cancer	0.000461	0.000912	CcSEcCtD
Anastrozole—Urticaria—Doxorubicin—liver cancer	0.00046	0.00091	CcSEcCtD
Anastrozole—Abdominal pain—Doxorubicin—liver cancer	0.000457	0.000905	CcSEcCtD
Anastrozole—Body temperature increased—Doxorubicin—liver cancer	0.000457	0.000905	CcSEcCtD
Anastrozole—Asthenia—Epirubicin—liver cancer	0.000449	0.000888	CcSEcCtD
Anastrozole—Pruritus—Epirubicin—liver cancer	0.000442	0.000875	CcSEcCtD
Anastrozole—Diarrhoea—Epirubicin—liver cancer	0.000428	0.000847	CcSEcCtD
Anastrozole—Hypersensitivity—Doxorubicin—liver cancer	0.000426	0.000844	CcSEcCtD
Anastrozole—Asthenia—Doxorubicin—liver cancer	0.000415	0.000821	CcSEcCtD
Anastrozole—Dizziness—Epirubicin—liver cancer	0.000413	0.000818	CcSEcCtD
Anastrozole—Pruritus—Doxorubicin—liver cancer	0.000409	0.00081	CcSEcCtD
Anastrozole—Vomiting—Epirubicin—liver cancer	0.000398	0.000787	CcSEcCtD
Anastrozole—Diarrhoea—Doxorubicin—liver cancer	0.000396	0.000783	CcSEcCtD
Anastrozole—Rash—Epirubicin—liver cancer	0.000394	0.00078	CcSEcCtD
Anastrozole—Dermatitis—Epirubicin—liver cancer	0.000394	0.000779	CcSEcCtD
Anastrozole—Headache—Epirubicin—liver cancer	0.000392	0.000775	CcSEcCtD
Anastrozole—Dizziness—Doxorubicin—liver cancer	0.000383	0.000757	CcSEcCtD
Anastrozole—Nausea—Epirubicin—liver cancer	0.000371	0.000735	CcSEcCtD
Anastrozole—Vomiting—Doxorubicin—liver cancer	0.000368	0.000728	CcSEcCtD
Anastrozole—Rash—Doxorubicin—liver cancer	0.000365	0.000722	CcSEcCtD
Anastrozole—Dermatitis—Doxorubicin—liver cancer	0.000364	0.000721	CcSEcCtD
Anastrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000364	0.00167	CbGpPWpGaD
Anastrozole—Headache—Doxorubicin—liver cancer	0.000362	0.000717	CcSEcCtD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—liver cancer	0.000361	0.00165	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—NAT2—liver cancer	0.00036	0.00165	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—GPX3—liver cancer	0.000358	0.00164	CbGpPWpGaD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000345	0.00158	CbGpPWpGaD
Anastrozole—Nausea—Doxorubicin—liver cancer	0.000344	0.00068	CcSEcCtD
Anastrozole—CYP2C9—Biological oxidations—HPGDS—liver cancer	0.000341	0.00156	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000339	0.00155	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—UGDH—liver cancer	0.000338	0.00155	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000337	0.00154	CbGpPWpGaD
Anastrozole—CYP1A2—Phase II conjugation—GSTP1—liver cancer	0.000335	0.00153	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000331	0.00152	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000326	0.00149	CbGpPWpGaD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000321	0.00147	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—EPT1—liver cancer	0.000318	0.00145	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000316	0.00144	CbGpPWpGaD
Anastrozole—CYP1A2—Phase II conjugation—GSTM1—liver cancer	0.000308	0.00141	CbGpPWpGaD
Anastrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000306	0.0014	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—GPX3—liver cancer	0.000306	0.0014	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000303	0.00139	CbGpPWpGaD
Anastrozole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000302	0.00138	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—liver cancer	0.000301	0.00138	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—TAT—liver cancer	0.000301	0.00138	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MTOR—liver cancer	0.000301	0.00138	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000299	0.00137	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000296	0.00136	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000295	0.00135	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—HPGDS—liver cancer	0.000292	0.00133	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000285	0.0013	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000281	0.00129	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—CYP2E1—liver cancer	0.000278	0.00127	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000278	0.00127	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—liver cancer	0.000277	0.00127	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	0.000276	0.00126	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	0.000276	0.00126	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP2E1—liver cancer	0.000274	0.00126	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	0.00027	0.00124	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00027	0.00123	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—liver cancer	0.000269	0.00123	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—JUN—liver cancer	0.000269	0.00123	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—liver cancer	0.000267	0.00122	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	0.000263	0.0012	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—GGT1—liver cancer	0.000255	0.00117	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.000255	0.00117	CbGpPWpGaD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000248	0.00114	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—CYP2E1—liver cancer	0.000238	0.00109	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000236	0.00108	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—liver cancer	0.000235	0.00107	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—CYP2E1—liver cancer	0.000234	0.00107	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.00023	0.00105	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—GSTP1—liver cancer	0.000229	0.00105	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	0.000226	0.00104	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000225	0.00103	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000222	0.00101	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—GGT1—liver cancer	0.000218	0.000999	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MYC—liver cancer	0.000216	0.000989	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.000211	0.000968	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	0.000211	0.000965	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—GSTM1—liver cancer	0.000211	0.000965	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	0.000208	0.000952	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GLUL—liver cancer	0.000205	0.000937	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CPT1B—liver cancer	0.000205	0.000937	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000203	0.000931	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—CYP1A1—liver cancer	0.0002	0.000915	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—liver cancer	0.0002	0.000914	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—NR1H4—liver cancer	0.000197	0.000903	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	0.000197	0.000902	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	0.000197	0.000901	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.000197	0.000901	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000196	0.000898	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—GSTP1—liver cancer	0.000196	0.000897	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.000195	0.000894	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTA3—liver cancer	0.000194	0.000888	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	0.000193	0.000885	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000183	0.00084	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000181	0.000828	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—GSTM1—liver cancer	0.00018	0.000825	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	0.000178	0.000813	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTA4—liver cancer	0.000177	0.000812	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—liver cancer	0.000177	0.000812	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000174	0.000795	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000173	0.000794	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTA2—liver cancer	0.000173	0.000792	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—CYP1A1—liver cancer	0.000171	0.000782	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000168	0.000771	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	0.000168	0.000771	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000168	0.000767	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTA1—liver cancer	0.000167	0.000764	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.000166	0.00076	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—NAT2—liver cancer	0.000165	0.000755	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000159	0.000726	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ALDOB—liver cancer	0.000158	0.000724	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000151	0.000693	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CRABP1—liver cancer	0.000151	0.000691	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00015	0.000686	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—liver cancer	0.00015	0.000686	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—UGDH—liver cancer	0.000149	0.000684	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000149	0.000683	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—EPT1—liver cancer	0.000141	0.000643	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000139	0.000636	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000137	0.000628	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000136	0.000622	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—TAT—liver cancer	0.000133	0.00061	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—HPGDS—liver cancer	0.000132	0.000604	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000132	0.000603	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000131	0.0006	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000131	0.0006	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.00013	0.000595	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000128	0.000586	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—UGDH—liver cancer	0.000128	0.000585	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—EPT1—liver cancer	0.00012	0.00055	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000119	0.000547	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000118	0.00054	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PSMA4—liver cancer	0.000118	0.000538	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PSMD10—liver cancer	0.000118	0.000538	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GOT2—liver cancer	0.000114	0.000523	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—TAT—liver cancer	0.000114	0.000521	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000112	0.000513	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYP2E1—liver cancer	0.000107	0.000492	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000104	0.000476	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYCS—liver cancer	0.000101	0.00046	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GOT1—liver cancer	9.87e-05	0.000452	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GGT1—liver cancer	9.87e-05	0.000452	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—UGDH—liver cancer	9.86e-05	0.000451	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	9.81e-05	0.000449	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—EPT1—liver cancer	9.27e-05	0.000424	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CPT1B—liver cancer	9.05e-05	0.000415	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GLUL—liver cancer	9.05e-05	0.000415	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTP1—liver cancer	8.86e-05	0.000406	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—TAT—liver cancer	8.78e-05	0.000402	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—HMOX1—liver cancer	8.74e-05	0.0004	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—NR1H4—liver cancer	8.73e-05	0.0004	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTA3—liver cancer	8.58e-05	0.000393	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	8.38e-05	0.000384	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTM1—liver cancer	8.15e-05	0.000373	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTA4—liver cancer	7.85e-05	0.000359	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GLUL—liver cancer	7.74e-05	0.000354	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CPT1B—liver cancer	7.74e-05	0.000354	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYP1A1—liver cancer	7.72e-05	0.000354	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	7.67e-05	0.000351	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTA2—liver cancer	7.65e-05	0.00035	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—NR1H4—liver cancer	7.46e-05	0.000342	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTA1—liver cancer	7.38e-05	0.000338	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTA3—liver cancer	7.33e-05	0.000336	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—NAT2—liver cancer	7.3e-05	0.000334	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—MTHFR—liver cancer	7.2e-05	0.00033	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PPARA—liver cancer	7.06e-05	0.000323	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	7.02e-05	0.000321	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ALDOB—liver cancer	7e-05	0.00032	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTA4—liver cancer	6.71e-05	0.000307	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CRABP1—liver cancer	6.68e-05	0.000306	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	6.56e-05	0.0003	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTA2—liver cancer	6.54e-05	0.000299	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.34e-05	0.00029	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTA1—liver cancer	6.31e-05	0.000289	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—NAT2—liver cancer	6.24e-05	0.000286	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CG—liver cancer	6.05e-05	0.000277	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	6.01e-05	0.000275	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	6e-05	0.000275	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ALDOB—liver cancer	5.98e-05	0.000274	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CPT1B—liver cancer	5.97e-05	0.000273	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GLUL—liver cancer	5.97e-05	0.000273	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PPARG—liver cancer	5.84e-05	0.000267	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—HPGDS—liver cancer	5.83e-05	0.000267	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.8e-05	0.000266	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—NR1H4—liver cancer	5.76e-05	0.000264	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CRABP1—liver cancer	5.7e-05	0.000261	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTA3—liver cancer	5.66e-05	0.000259	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CD—liver cancer	5.32e-05	0.000243	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.28e-05	0.000242	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ALB—liver cancer	5.25e-05	0.00024	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.22e-05	0.000239	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PSMA4—liver cancer	5.2e-05	0.000238	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PSMD10—liver cancer	5.2e-05	0.000238	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTA4—liver cancer	5.18e-05	0.000237	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.14e-05	0.000235	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GOT2—liver cancer	5.06e-05	0.000232	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTA2—liver cancer	5.05e-05	0.000231	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—HPGDS—liver cancer	4.99e-05	0.000228	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.96e-05	0.000227	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTA1—liver cancer	4.87e-05	0.000223	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—NAT2—liver cancer	4.81e-05	0.00022	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP2E1—liver cancer	4.76e-05	0.000218	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CB—liver cancer	4.63e-05	0.000212	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ALDOB—liver cancer	4.61e-05	0.000211	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.61e-05	0.000211	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.51e-05	0.000207	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.46e-05	0.000204	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYCS—liver cancer	4.45e-05	0.000204	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PSMA4—liver cancer	4.44e-05	0.000203	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PSMD10—liver cancer	4.44e-05	0.000203	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CRABP1—liver cancer	4.4e-05	0.000202	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GOT1—liver cancer	4.37e-05	0.0002	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GGT1—liver cancer	4.37e-05	0.0002	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GOT2—liver cancer	4.32e-05	0.000198	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP2E1—liver cancer	4.06e-05	0.000186	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.94e-05	0.00018	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTP1—liver cancer	3.92e-05	0.00018	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—HMOX1—liver cancer	3.87e-05	0.000177	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—HPGDS—liver cancer	3.85e-05	0.000176	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYCS—liver cancer	3.8e-05	0.000174	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GOT1—liver cancer	3.73e-05	0.000171	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GGT1—liver cancer	3.73e-05	0.000171	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTM1—liver cancer	3.6e-05	0.000165	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PSMD10—liver cancer	3.43e-05	0.000157	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PSMA4—liver cancer	3.43e-05	0.000157	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP1A1—liver cancer	3.42e-05	0.000156	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTP1—liver cancer	3.35e-05	0.000153	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GOT2—liver cancer	3.34e-05	0.000153	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—HMOX1—liver cancer	3.31e-05	0.000151	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—MTHFR—liver cancer	3.19e-05	0.000146	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP2E1—liver cancer	3.14e-05	0.000144	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PPARA—liver cancer	3.13e-05	0.000143	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTM1—liver cancer	3.08e-05	0.000141	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYCS—liver cancer	2.93e-05	0.000134	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP1A1—liver cancer	2.92e-05	0.000134	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GOT1—liver cancer	2.88e-05	0.000132	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GGT1—liver cancer	2.88e-05	0.000132	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CA—liver cancer	2.83e-05	0.000129	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.81e-05	0.000129	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—MTHFR—liver cancer	2.72e-05	0.000125	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CG—liver cancer	2.68e-05	0.000123	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PPARA—liver cancer	2.67e-05	0.000122	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTP1—liver cancer	2.59e-05	0.000118	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PPARG—liver cancer	2.58e-05	0.000118	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—HMOX1—liver cancer	2.55e-05	0.000117	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.4e-05	0.00011	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTM1—liver cancer	2.38e-05	0.000109	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CD—liver cancer	2.35e-05	0.000108	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ALB—liver cancer	2.32e-05	0.000106	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—AKT1—liver cancer	2.31e-05	0.000106	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CG—liver cancer	2.29e-05	0.000105	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP1A1—liver cancer	2.25e-05	0.000103	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PPARG—liver cancer	2.21e-05	0.000101	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—MTHFR—liver cancer	2.1e-05	9.62e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PPARA—liver cancer	2.06e-05	9.44e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CB—liver cancer	2.05e-05	9.39e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CD—liver cancer	2.01e-05	9.21e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ALB—liver cancer	1.98e-05	9.09e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CG—liver cancer	1.77e-05	8.08e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CB—liver cancer	1.75e-05	8.02e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PPARG—liver cancer	1.7e-05	7.8e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CD—liver cancer	1.55e-05	7.1e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ALB—liver cancer	1.53e-05	7.01e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CB—liver cancer	1.35e-05	6.19e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CA—liver cancer	1.25e-05	5.72e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CA—liver cancer	1.07e-05	4.89e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—AKT1—liver cancer	1.02e-05	4.68e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—AKT1—liver cancer	8.73e-06	4e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CA—liver cancer	8.25e-06	3.77e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—AKT1—liver cancer	6.74e-06	3.08e-05	CbGpPWpGaD
